Therapy Areas: Autoimmune
15 January 2019 - - US-based business intelligence and market research company Spherix Global Insights has published the third annual edition of RealWorld Dynamix: Biologic/JAK Switching in IBD, ...
15 January 2019 - iReceptor Plus stated on Tuesday that European Union (EU) and the Canadian government have awarded EUR8.4m under its international consortium project to promote human immunological d...
14 January 2019 - - Chinese biotechnology company Bio-Thera Solutions Ltd has reached a licensing agreement with Indian pharmaceutical company Cipla Ltd. (BSE: 500087) (NSE: CIPLA EQ) for BAT1706, its...
8 January 2019 - - UK-based T Cell Receptor biotechnology company Immunocore Ltd has appointed Bahija Jallal as chief executive officer and director of the board, the company said.

With m...
7 January 2019 - United States-based Pfizer has commenced a phase 2b/3 clinical trial of PF-06651600, an oral JAK3 inhibitor, intended to treat patients with moderate to severe alopecia areata, it was...
2 January 2019 - - The US Food and Drug Administration granted tentative approval on November 16, 2018 of US-based specialty pharmaceutical company Banner Life Sciences LLC's New Drug Application...